8-K: ModivCare Reports Mixed Q4 Results, Issues 2024 Guidance

ModivCare's fourth quarter results show revenue growth but a net loss, with 2024 guidance projecting continued revenue growth and improved profitability.

Summary

• ModivCare reported a 7.5% increase in service revenue for the fourth quarter of 2023, reaching $702.8 million, compared to $653.9 million in the same period of 2022.
• The company experienced a net loss of $5.3 million, or $0.37 per diluted share, in Q4 2023, an improvement from a net loss of $6.9 million in Q4 2022.
• Adjusted EBITDA for Q4 2023 was $50.5 million, with adjusted net income at $18.4 million, or $1.29 per diluted share.
• For the full year 2023, service revenue increased by 9.9% to $2,751.2 million, up from $2,504.4 million in 2022.
• The full year net loss was $204.5 million, or $14.43 per diluted share, primarily due to a $183.1 million non-cash goodwill impairment.
• Adjusted EBITDA for the full year was $204.4 million, with adjusted net income at $79.9 million, or $5.60 per diluted share.
• ModivCare won $216.2 million in NEMT TCV during Q4 2023 and $463.5 million for the full year, with $10.6 million in ACV for remote patient monitoring.
• The company drew $113.8 million on its $325 million revolving credit facility and amended the leverage covenant in early 2024 to ensure sufficient liquidity.
• 2024 guidance projects revenue between $2.7 billion and $2.9 billion and adjusted EBITDA between $190 million and $210 million.

Sentiment

Score: 4

Explanation: The document presents mixed results with revenue growth offset by significant losses and negative cash flow. While there are positive aspects like new contract wins and cost-saving initiatives, the overall sentiment is cautious due to the financial challenges and risks.

Positives

• Service revenue showed solid growth in both Q4 and the full year 2023.
• The company secured significant new contracts in the NEMT segment.
• ModivCare is implementing cost-saving initiatives and expects to see benefits in 2024 and 2025.
• The company is experiencing growth in personal care and remote patient monitoring segments.
• The amendment to the leverage covenant provides additional cushion for credit facility availability, ensuring sufficient liquidity.

Negatives

• The company reported a net loss of $5.3 million in Q4 2023 and a significant net loss of $204.5 million for the full year 2023.
• Adjusted EBITDA was lower in 2023 compared to 2022 due to higher service expenses in the NEMT segment.
• The company experienced negative free cash flow of $36.8 million in Q4 2023 and $125.3 million for the full year.
• There was a delay in payment from a single client, impacting operating cash flow.
• Medicaid redetermination impacts have led to a decrease in average monthly members.

Risks

• The company faces risks related to government funding reductions and changes in payment models.
• There are concerns about the company's ability to control reimbursement rates and maintain cost of services.
• The company is exposed to risks related to public health emergencies and security breaches of information technology systems.
• The company faces challenges in attracting and retaining qualified employees.
• There are risks associated with the company's substantial indebtedness and lease obligations.
• The company is subject to risks related to the competitive remote patient monitoring industry and the need to innovate and maintain market acceptance.
• The company is exposed to risks related to the loss of Medicaid coverage by a significant number of Medicaid beneficiaries following the expiration of the COVID-19 public health emergency.

Future Outlook

ModivCare anticipates implementing approximately $150 million in annual contract value starting in the second quarter of 2024, along with $30 million in cost savings. 2024 revenue is projected to be between $2.7 billion and $2.9 billion, with adjusted EBITDA between $190 million and $210 million.

Management Comments

• L. Heath Sampson, President and CEO, stated that the company delivered solid financial results for 2023 with revenue and adjusted EBITDA meeting guidance.
• He also noted that the company's transformation has led to substantial operational improvement and a sharpened strategic focus.
• Management expects that financial results will lag foundational changes and has encountered near-term financial headwinds due to COVID-related working capital needs and margin pressure in the NEMT segment.

Industry Context

The healthcare services industry is facing challenges related to changing payment models, cost containment, and the impact of public health emergencies. ModivCare's focus on integrated supportive care solutions and addressing social determinants of health aligns with broader industry trends. The company's growth in remote patient monitoring also reflects the increasing adoption of telehealth and digital health solutions.

Comparison to Industry Standards

• ModivCare's revenue growth of 9.9% for the full year 2023 is comparable to other companies in the healthcare services sector, such as CareCentrix, which also focuses on care management and coordination.
• However, the net loss of $204.5 million for the full year is a significant concern, especially when compared to companies like UnitedHealth Group, which consistently report profits.
• The adjusted EBITDA margin of 7.4% for the full year is lower than some of its peers, such as Humana, which typically have higher margins in their healthcare services segments.
• The company's focus on NEMT, personal care, and remote patient monitoring is similar to companies like LogistiCare, but ModivCare's technology-enabled approach differentiates it.
• The negative free cash flow of $125.3 million for the full year is a point of concern, as many established healthcare service providers generate positive cash flow.

Stakeholder Impact

• Shareholders may be concerned about the net loss and negative cash flow, but encouraged by revenue growth and cost-saving initiatives.
• Employees may be impacted by restructuring and cost-saving measures.
• Customers may benefit from the company's focus on improving patient outcomes and addressing social determinants of health.
• Suppliers may be affected by changes in the company's operations and cost-saving initiatives.
• Creditors may be concerned about the company's substantial indebtedness and negative cash flow.

Next Steps

• The company will implement approximately $150 million in annual contract value starting in the second quarter of 2024.
• ModivCare will focus on cost savings initiatives, including digitization, to mitigate the effects of Medicaid redetermination.
• The company will continue to roll out core platforms and new capabilities in personal care and remote patient monitoring segments.
• Modivcare will hold a conference call to discuss its financial results on Friday, February 23, 2024 at 8:30 a.m. ET.

Key Dates

Keywords

NEMT, healthcare services, remote patient monitoring, personal care services, Medicaid, EBITDA, revenue, financial results, contract value, cost savings